USA - NYSE:TBI - US89785X1019 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to TBI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-08-06 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-07 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-06-17 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-07 | Baird | Maintains | Outperform -> Outperform |
| 2023-07-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-05-22 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2023-04-26 | BMO Capital | Maintains | Market Perform |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2022-07-27 | BMO Capital | Maintains | Market Perform |
| 2022-07-26 | Baird | Maintains | Outperform |
| 2022-05-26 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2021-04-27 | Baird | Upgrade | Neutral -> Outperform |
| 2021-04-27 | Credit Suisse | Maintains | Neutral |
7 analysts have analysed TBI and the average price target is 8.84 USD. This implies a price increase of 91.34% is expected in the next year compared to the current price of 4.62.
The consensus rating for TRUEBLUE INC (TBI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.